An introduction to pyrrolizidine alkaloids (PAs) – potentially deadly plant toxins with the potential to harm consumers of plant-based foods, beverages and dietary supplements.
Elemental analysis and metal analysis of lubricants and oils play a crucial role in many industries - supporting optimal performance and failure analysis in equipment, as well as quality control (QC) and regulatory compliance.
This article outlines some of the key global safeguards for keeping food safe from veterinary drug residues - such as the Codex Alimentarius, Maximum Residue Limits (MRLs), prohibited substances, residue surveillance plans, and VMP testing.
We examine the global opioid epidemic – explaining how close to a million people have already lost their lives, and why there has never been a more dangerous time to take street drugs than today.
Discover LGC Standards PFAS Hub for comprehensive PFAS testing methods, analysis, and solutions to detect PFAS in water, ensuring regulatory compliance and accurate detection.
Despite concerns about their health and environmental effects, more pesticides are likely to be used in future – meaning that accurate testing for banned, unauthorised or restricted compounds is even more vital now than ever.
To mark Breast Cancer Awareness Month, we highlight new research showing how breast cancer cells rely on specific metabolic pathways for growth and metastasis, paving the way for an effective multimodal treatment strategy.
Athletes have been ‘doping’ – or taking performance enhancing substances – for over 2,000 years, but antidoping science and regulation only really began in in the late 20th century.
Nanotechnology is revolutionising drug delivery by tackling the solubility and bioavailability challenges that lead to many drugs failing clinical trials.
We provide courses on topics such as method validation, measurement uncertainty, statistics and more, all designed to help laboratories ensure the reliability of their results and meet accreditation and regulatory requirements.
The World Health organisation (WHO) has released new recommendations for limiting the presence of potentially carcinogenic nitrosamine impurities in medicines.
Drug discovery has reached another significant milestone with the large-scale synthesis of E7130 – an unprecedentedly complex anticancer drug candidate.
